| Product Name | MF | CAS | Details |
|---|
| Bax inhibitor peptide V5 acetate, 10 mM in DMSO | Details |
| SZL P1-41, 10 mM in DMSO | C24H24N2O3S | 222716-34-9 | Details |
| CPI-0610 carboxylic acid | C20H15ClN2O3 | 1380089-81-5 | Details |
| VH032-cyclopropane-F, 10 mM in DMSO | C26H33FN4O5S | 2306193-99-5 | Details |
| 1-Myristoyl-2-stearoyl-sn-glycero-3-phosphocholine | C40H80NO8P | 76343-22-1 | Details |
| PKA inhibitor fragment (6-22) amide Acetate, 10 mM in DMSO | Details |
| Desformylflustrabromine hydrochloride | C16H22BrClN2 | 951322-11-5 | Details |
| SYP-5, 10 mM in DMSO | C18H16O3S | 1384268-04-5 | Details |
| SYM2206, 10 mM in DMSO | C20H22N4O3 | 173952-44-8 | Details |
| Vipivotide tetraxetan | C49H71N9O16 | 1702967-37-0 | Details |
| SMARCA-BD ligand 1 for Protac dihydrochloride | C14H18ClN5O | 2369053-68-7 | Details |
| Thalidomide-O-amido-PEG-C2-NH2 hydrochloride, 10 mM in DMSO | C19H23ClN4O7 | 2204226-02-6 | Details |
| Cytochrome c - pigeon (88-104) Acetate | Details |
| Acetyl Angiotensinogen (1-14), porcine Acetate | Details |
| Ac-Endothelin-1 (16-21), human acetate | Details |
| β-Interleukin I (163-171), human Acetate, 10 mM in DMSO | Details |
| Epidermal Growth Factor Receptor Peptide Acetate, 10 mM in DMSO | Details |
| (Rac)-5-Keto Fluvastatin | C24H24FNO4 | 1160169-39-0 | Details |
| Dabigatran ethyl ester hydrochloride, 10 mM in DMSO | C27H30ClN7O3 | 211914-50-0 | Details |
| 4-Azido-L-phenylalanine hydrochloride, 10 mM in DMSO | C9H11ClN4O2 | 34670-43-4 | Details |
| N-(2-Chloro-6-methylphenyl)-N''-4-pyridinylurea, 10 mM in DMSO | C13H12ClN3O | 97627-24-2 | Details |
| SX-682, 10 mM in DMSO | C19H14BF4N3O4S | 1648843-04-2 | Details |
| Mal-PEG1-Val-Cit-OH | Details |
| 1-Oleoyl lysophosphatidic acid sodium | C21H40NaO7P | 325465-93-8 | Details |
| T16Ainh-A01 | C19H20N4O3S2 | 552309-42-9 | Details |
| T-00127_HEV1, 10 mM in DMSO | C22H29N5O3 | 900874-91-1 | Details |
| (2R,3S)-Azelaprag | C25H29N7O4S | 2049979-31-7 | Details |
| SW155246, 10 mM in DMSO | C16H11ClN2O5S | 420092-79-1 | Details |
| SXC 2023 | C13H15NO4S | 1695562-36-7 | Details |
| T0070907, 10 mM in DMSO | C12H8ClN3O3 | 313516-66-4 | Details |
| PKA inhibitor fragment (6-22) amide Acetate | Details |
| Beta-Sheet Breaker Peptide iAβ5 Acetate, 10 mM in DMSO | Details |
| Beta-Lipotropin (1-10), porcine Acetate, 10 mM in DMSO | Details |
| Propargyl-PEG17-methane | C36H70O17 | 2169967-47-7 | Details |
| (S,R,S)-AHPC-PEG3-NH2 hydrochloride | C30H46ClN5O7S | 2097971-11-2 | Details |
| Cl-C6-PEG4-O-CH2COOH | C16H31ClO7 | 1799506-30-1 | Details |
| Thalidomide-O-amido-C6-NH2 hydrochloride | C21H27ClN4O6 | 2376990-31-5 | Details |
| β-Interleukin I (163-171), human Acetate | Details |
| Systemin acetate(137181-56-7 free base) | Details |
| Acetyl Angiotensinogen (1-14), porcine Acetate, 10 mM in DMSO | Details |
| 1-(1-Naphthyl) piperazine hydrochloride, 10 mM in DMSO | C14H17ClN2 | 104113-71-5 | Details |
| SB399885, 10 mM in DMSO | C18H21Cl2N3O4S | 402713-80-8 | Details |
| SW033291, 10 mM in DMSO | C21H20N2OS3 | 459147-39-8 | Details |
| N-Desethyl Chloroquine Hydrochloride | C16H23Cl2N3 | 15912-96-6 | Details |
| Dynamin inhibitory peptide Acetate | Details |
| Aspartyl-alanyl-diketopiperazine acetate, 10 mM in DMSO | Details |
| (S,R,S)-AHPC-PEG4-NH2 | C32H49N5O8S | 2010159-57-4 | Details |
| SYR127063, 10 mM in DMSO | C23H20ClF3N4O3 | 871026-18-5 | Details |
| SW-100, 10 mM in DMSO | C17H17ClN2O2 | 2126744-35-0 | Details |
| Carcinine ditrifluoroacetate Acetate | C8H14N4O | Details |
| T-0156 | C31H29N5O7 | 324572-92-1 | Details |
| SynuClean-D, 10 mM in DMSO | C13H5F3N4O5 | 685121-45-3 | Details |
| UK 227786, 10 mM in DMSO | C22H21ClN4O4.ClH | 150452-21-4 | Details |
| 2,3-dihydrothieno-Thiadiazole Carboxylate | C6H4N2O2S2 | 152467-47-5 | Details |
| SW044248, 10 mM in DMSO | C22H23N5O2S | 522650-83-5 | Details |
| Syk Inhibitor II, 10 mM in DMSO | C14H15F3N6O | 726695-51-8 | Details |
| Synta66, 10 mM in DMSO | C20H17FN2O3 | 835904-51-3 | Details |
| 2,3,4,6-Tetra-o-acetyl-alpha-galactosylpyranosyl bromide | C14H19BrO9 | 529493-92-3 | Details |
| (S,R,S)-AHPC-PEG4-N3 | C32H47N7O8S | 1797406-81-5 | Details |
| Thalidomide-O-amido-C6-NH2 TFA, 10 mM in DMSO | C23H27F3N4O8 | 1950635-14-9 | Details |
| diABZI STING agonist-1 (Tautomerism) | C42H51N13O7 | 2138498-18-5 | Details |
| Omeprazole metabolite Omeprazole sulfone | C17H19N3O4S | 88546-55-8 | Details |
| I-OMe-Tyrphostin AG 538, 10 mM in DMSO | C17H12INO5 | 1094048-77-7 | Details |
| Anti-Inflammatory Peptide 1 Acetate, 10 mM in DMSO | Details |
| Cytochrome c - pigeon (88-104) Acetate, 10 mM in DMSO | Details |
| SY-5609, 10 mM in DMSO | C23H26F3N6OP | 2417302-07-7 | Details |
| Dihydroxyacetone phosphate hemimagnesium salt hydrate | Details |
| eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) (387-394) [Multiple species]（TFA) | Details |
| T-1095, 10 mM in DMSO | C26H28O11 | 209746-59-8 | Details |
| Anti-Inflammatory Peptide 1 Acetate | Details |
| Epidermal Growth Factor Receptor Peptide Acetate | Details |
| DMAB-anabaseine dihydrochloride | C19H22ClN3 | 154149-38-9 | Details |
| Dynamin inhibitory peptide Acetate, 10 mM in DMSO | Details |
| GnRH Associated Peptide (GAP) (1-13), human Acetate, 10 mM in DMSO | Details |
| Beta-Sheet Breaker Peptide iAβ5 Acetate | Details |
| T-2000 | C20H20N2O5 | 97846-21-4 | Details |
| NOT Receptor Modulator 1, 10 mM in DMSO | C22H19ClN2O | 1015231-98-7 | Details |
| T-0509 | C18H23NO5 | 96843-99-1 | Details |
| (4R)-RO5263397 | C10H11FN2O | 1357266-80-8 | Details |
| Beta-Lipotropin (1-10), porcine Acetate | Details |
| SYM 2081 | C6H11NO4 | 31137-74-3 | Details |
| SW106065, 10 mM in DMSO | C10H8N2OS | 62289-81-0 | Details |
| SW2_110A | C42H60N6O7 | 2579696-95-8 | Details |
| Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate | C27H36N2O4 | 2725484-87-5 | Details |
| SY-640 | C11H13NO3 | 168705-70-2 | Details |
| GnRH Associated Peptide (GAP) (1-13), human Acetate | C65H101N15O25 | Details |
| Bax inhibitor peptide V5 acetate | Details |
| NPS ALX Compound 4a hydrochloride(1:1), 10 mM in DMSO | Details |
| AZ-Dyrk1B-33, 10 mM in DMSO | C19H16N4 | 1679330-37-0 | Details |
| T025, 10 mM in DMSO | C21H18N8 | 2407433-00-3 | Details |
| NPS ALX Compound 4a hydrochloride(1:1) | Details |
| Syntide 2 acetate(108334-68-5 free base) | Details |
| AZ 11645373, 10 mM in DMSO | C24H21N3O5S | 227088-94-0 | Details |
| Syk Inhibitor II dihydrochloride, 10 mM in DMSO | C14H16ClF3N6O | 227449-73-2 | Details |
| FBPase-1 inhibitor-1, 10 mM in DMSO | C13H7Cl3N2O3S | 883973-99-7 | Details |
| Dimebolin, 10 mM in DMSO | C21H25N3 | 3613-73-8 | Details |
| Azepexole hydrochloride, 10 mM in DMSO | C9H16ClN3O | 147663-20-5 | Details |
| T0901317, 10 mM in DMSO | C17H12F9NO3S | 293754-55-9 | Details |
| Syk Inhibitor II hydrochloride, 10 mM in DMSO | C14H16ClF3N6O | 2490508-82-0 | Details |
| T-1101 tosylate, 10 mM in DMSO | C31H31N5O6S3 | 2250404-95-4 | Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 | ||||